The primary aim was To guage the efficacy in the vaccine versus placebo in lowering cocaine use. Secondary goals integrated confirming vaccine immunogenicity as a result of IgG anti-cocaine antibody levels and assessing the security and tolerability of vaccination via a twenty week review and at 24 7 days comply https://mitchk963fcy7.wikissl.com/user